Linkage studies with 17q and 18q markers in a breast/ovarian cancer family
- Univ. of Aberdeen (United Kingdom)
- Aberdeen Royal Infirmary (United Kingdom)
Genes on chromosomes 17q and 18q have been shown to code for putative tumor suppressors. By a combination of allele-loss studies on sporadic ovarian carcinomas and linkage analysis on a breast/ovarian cancer family, the authors have investigated the involvement of such genes in these diseases. Allele loss occurred in sporadic tumors from both chromosome 17p, in 18/26 (69%) cases, and chromosome 17q, in 15/22 (68%) cases. In the three familial tumors studied, allele loss also occurred on chromosome 17 (in 2/3 cases for 17p markers and in 2/2 cases for a 17q allele). Allele loss on chromosome 18q, at the DCC (deleted in colorectal carcinomas) locus, was not as common (6/16 cases [38%]) in sporadic ovarian tumors but had occurred in all three familial tumors. The results of linkage analysis on the breast/ovarian cancer family suggested linkage between the disease locus and 17q markers, with a maximum lod score of 1.507 obtained with Mfd188 (D17S579) polymorphism at 5% recombination. The maximum lod score for DCC was 0.323 at 0.1% recombination. In this family the results are consistent with a predisposing gene for breast/ovarian cancer being located at chromosome 17q21. 24 refs., 1 fig., 3 tabs.
- OSTI ID:
- 6288320
- Journal Information:
- American Journal of Human Genetics; (United States), Vol. 52:4; ISSN 0002-9297
- Country of Publication:
- United States
- Language:
- English
Similar Records
Chromosome 17q linkage studies of 18 Utah breast cancer kindreds
Inter- and intra-individual variability in somatic allele loss in ductal carcinoma of the breast